WHILE supporting health minister
Peter Dutton’s decision to dismantle
the Pharmaceutical Benefits Pricing
Authority in hope that this speeds
up the listing of medicines on the
Pharmaceutical Benefits Scheme,
the Consumer Health Forum (CHF)
has concerns that this removes a
consumer representative from the
overall PBS pre-listing process.
While the CHF says this decision
shouldn’t impact negatively on
the process, but “strengthening
the consumer voice on the PBAC
would be achieved by appointing
a second consumer representative
to the PBAC and enhancing the
consumer submission process, by
such measures as making provision
for the PBAC to hear from patient
groups directly,” CHF spokesman
Mark Metherell said.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.